Anosmia and ageusia have been widely reported in COVID-19 patients in Italy, especially in younger patients. Out of 417 patients with mild to moderate COVID-19 in Milan, Italy, 85.6% reported olfactory dysfunction, and from 202 patients with mild COVID-19 symptoms in another hospital in Italy, 64.4% had impaired sense of smell or taste. In Wuhan, China, among 214 patients hospitalized for COVID-19 symptoms, only 5.1% and 5.6% had impaired smell or taste, with impairment more prevalent among patients with mild rather than severe COVID-19 (6-7% versus 3.0%).